BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
1/20/2015 9:10:00 PM | Browse: 1431 | Download: 1694
 |
Received |
|
2014-06-29 14:16 |
|
Peer-Review Started |
|
2014-06-29 21:42 |
 |
First Decision by Editorial Office Director |
|
|
|
Return for Revision |
|
2014-08-15 16:47 |
|
Revised |
|
2014-08-31 00:10 |
|
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2014-11-27 13:18 |
|
Second Decision by Editor-in-Chief |
|
2014-11-27 18:32 |
|
Final Decision by Editorial Office Director |
|
2014-12-08 16:01 |
|
Articles in Press |
|
2014-12-08 17:06 |
|
Edit the Manuscript by Language Editor |
|
2014-12-21 18:01 |
|
Typeset the Manuscript |
|
2015-01-06 12:08 |
|
Publish the Manuscript Online |
|
2015-01-20 20:12 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
|
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Transplantation |
| Manuscript Type |
Minireviews |
| Article Title |
Recent advances in the prevention of Hepatitis B recurrence after liver transplantation
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Zhi-Feng Xi and Qiang Xia |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Shanghai Jiaotong University School of Medicine Science and Technology Fund |
11XJ21016 |
| Training Program for Super Academic Leaders in the Shanghai Health System |
XBR2011029 |
|
| Corresponding Author |
Qiang Xia, Professor, Department of Liver Surgery, Ren Ji Hospital, School of Medicine, Shanghai Jiaotong University, No. 160 Pujian Road, Shanghai 200127, China. xiaqiang@medmail.com.cn |
| Key Words |
Liver transplantation; Hepatitis B recurrence; Hepatitis B immunoglobulin; Lamivudine; Entecavir; Tenofovir |
| Core Tip |
The strategy of hepatitis B immunoglobulin (HBIG) combined with lamivudine has been the standard treatment for the prophylaxis of hepatitis B virus recurrence after liver transplantation. However, the high resistance rate of lamivudine and the many disadvantages of HBIG have compelled surgeons to reconsider the long-term efficacy of this strategy for the prevention of hepatitis B reinfection. This review discusses new strategies for prophylaxis of the recurrence of hepatitis B after liver transplantation.
|
| Publish Date |
2015-01-20 20:12 |
| Citation |
Xi ZF, Xia Q. Recent advances in prevention of hepatitis B recurrence after liver transplantation. World J Gastroenterol 2015; 21(3): 829-835 |
| URL |
http://www.wjgnet.com/1007-9327/full/v21/i3/829.htm |
| DOI |
http://dx.doi.org/10.3748/wjg.v21.i3.829 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
